These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 16424057)

  • 1. Diagnostic markers of ovarian cancer by high-throughput antigen cloning and detection on arrays.
    Chatterjee M; Mohapatra S; Ionan A; Bawa G; Ali-Fehmi R; Wang X; Nowak J; Ye B; Nahhas FA; Lu K; Witkin SS; Fishman D; Munkarah A; Morris R; Levin NK; Shirley NN; Tromp G; Abrams J; Draghici S; Tainsky MA
    Cancer Res; 2006 Jan; 66(2):1181-90. PubMed ID: 16424057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro screening of ovarian tumor specific peptides from a phage display peptide library.
    Zhang L; Yin G; Yan D; Wei Y; Ma C; Huang Z; Liao X; Yao Y; Chen X; Hao B
    Biotechnol Lett; 2011 Sep; 33(9):1729-35. PubMed ID: 21544611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review: Tumor-associated antigen autoantibodies and ovarian cancer early detection.
    Fortner RT; Damms-Machado A; Kaaks R
    Gynecol Oncol; 2017 Nov; 147(2):465-480. PubMed ID: 28800944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epitomics: serum screening for the early detection of cancer on microarrays using complex panels of tumor antigens.
    Draghici S; Chatterjee M; Tainsky MA
    Expert Rev Mol Diagn; 2005 Sep; 5(5):735-43. PubMed ID: 16149876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative evaluation of serum CA 125 levels in patients with primary epithelial ovarian cancer.
    Einhorn N; Bast RC; Knapp RC; Tjernberg B; Zurawski VR
    Obstet Gynecol; 1986 Mar; 67(3):414-6. PubMed ID: 2418395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the expression of human tumor antigens in ovarian cancer tissues.
    Ali-Fehmi R; Chatterjee M; Ionan A; Levin NK; Arabi H; Bandyopadhyay S; Shah JP; Bryant CS; Hewitt SM; O'Rand MG; Alekseev OM; Morris R; Munkarah A; Abrams J; Tainsky MA
    Cancer Biomark; 2010; 6(1):33-48. PubMed ID: 20164540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer.
    Baron AT; Boardman CH; Lafky JM; Rademaker A; Liu D; Fishman DA; Podratz KC; Maihle NJ
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):306-18. PubMed ID: 15734951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ovarian cancer--a comparison between CT diagnosis and serum tumor markers].
    Wakabayashi Y; Yachida M; Akata S; Kawana K; Kotake F; Kakizaki D; Abe K; Negishi N; Akiya K
    Gan No Rinsho; 1988 Jan; 34(1):52-6. PubMed ID: 3422324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The construction of cDNA library and the screening of related antigen of ascitic tumor cells of ovarian cancer.
    Hou Q; Chen K; Shan Z
    Eur J Gynaecol Oncol; 2015; 36(5):590-4. PubMed ID: 26513889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of malignant ovarian neoplasms: a review of the literature. III. Immunological detection and ovarian cancer-associated antigens.
    Smith LH; Oi RH
    Obstet Gynecol Surv; 1984 Jun; 39(6):346-60. PubMed ID: 6203071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of antibody biomarkers using protein microarrays of tumor antigens cloned in high throughput.
    Chatterjee M; Wojciechowski J; Tainsky MA
    Methods Mol Biol; 2009; 520():21-38. PubMed ID: 19381945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation of circulating serum sialyl Tn antigen levels in patients with epithelial ovarian cancer.
    Kobayashi H; Terao T; Kawashima Y
    J Clin Oncol; 1991 Jun; 9(6):983-7. PubMed ID: 1851822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiling tumor-associated autoantibodies for the detection of colon cancer.
    Ran Y; Hu H; Zhou Z; Yu L; Sun L; Pan J; Liu J; Yang Z
    Clin Cancer Res; 2008 May; 14(9):2696-700. PubMed ID: 18451234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CA125 antigen levels in obstetric and gynecologic patients.
    Niloff JM; Knapp RC; Schaetzl E; Reynolds C; Bast RC
    Obstet Gynecol; 1984 Nov; 64(5):703-7. PubMed ID: 6208522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor markers in the management of patients with ovarian cancer.
    Tuxen MK; Sölétormos G; Dombernowsky P
    Cancer Treat Rev; 1995 May; 21(3):215-45. PubMed ID: 7656266
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunodiagnosis of ovarian tumors.
    Jacobs I; Bast RC
    Immunol Ser; 1990; 53():323-38. PubMed ID: 2100566
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical study of autoantibody spectrum against ovarian cancer associated antigens combined with CA(125) in detecting and monitoring ovarian cancer].
    Yang ZJ; Yang G; Jiang YM; Ran YL; Yang ZH; Zhang W; Zhang JQ; Pan ZM; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2011 Feb; 46(2):113-8. PubMed ID: 21426769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-reactive immunoglobulins in ovarian cancer: diagnostic and therapeutic significance? (review).
    Taylor DD; Gercel-Taylor C
    Oncol Rep; 1998; 5(6):1519-24. PubMed ID: 9769398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of humoral responses of ovarian cancer patients: antibody subclasses and antigenic components.
    Taylor DD; Atay S; Metzinger DS; Gercel-Taylor C
    Gynecol Oncol; 2010 Feb; 116(2):213-21. PubMed ID: 19945743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New technologies for the identification of markers for early detection of ovarian cancer.
    Bandera CA; Ye B; Mok SC
    Curr Opin Obstet Gynecol; 2003 Feb; 15(1):51-5. PubMed ID: 12544502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.